Navigation
Home covid-19 Pfizer Pfizer, BioNTech start testing Omicron vaccine

Pfizer, BioNTech start testing Omicron vaccine

Pfizer, BioNTech start testing Omicron vaccine
January 25, 2022 Excelsio Media
Share To:
Pfizer and BioNTech said they started a clinical trial to test a new version of their vaccine specifically designed to target the COVID-19 Omicron variant.

Share
Tags covid-19 Pfizer

Excelsio Media

EXCELSIO Media, is an independent source of news and information.

View Profile
covid-19 Pfizer

Post A Comment:

0 comments:

Leave a comment. Thanks!

Subscribe to: Post Comments (Atom)